
For many women, PMOS (earlier known as PCOS) is first identified through irregular periods, weight changes or difficulty conceiving. However, Polyendocrine Metabolic Ovarian Syndrome (PMOS) affects more than reproductive health. It can also influence how the body responds to insulin, increasing the risk of elevated blood sugar and type 2 diabetes.
This connection becomes particularly important when planning pregnancy, as identifying metabolic concerns early can help doctors manage potential risks for both mother and baby.
How Is PMOS Linked to High Blood Sugar?
Insulin is a hormone that helps regulate blood sugar by allowing glucose to enter the body’s cells. In many women with PMOS, the body becomes less responsive to insulin, a condition known as insulin resistance. To compensate, the body may produce higher levels of insulin.
Higher insulin levels can stimulate excess androgen production in the ovaries. Although androgens are naturally present in women, elevated levels can interfere with ovulation, leading to irregular menstrual cycles and difficulty conceiving. Insulin resistance can also increase the risk of developing type 2 diabetes over time.
Why Do Health Risks Differ?
Not all women with PMOS experience the same metabolic changes. Insulin resistance can occur even in women who are not overweight, making blood sugar assessment relevant regardless of body weight.
A 2025 study conducted at IPGMER, Kolkata, examined 126 women with different forms of PMOS. It found that approximately 20% of women in two subgroups had metabolic syndrome, compared with around 7–8% in the other groups. Metabolic syndrome refers to a combination of conditions, including raised blood sugar, high blood pressure and unhealthy cholesterol levels.
Although the study was relatively small, its findings highlight why menstrual symptoms and body weight alone may not provide a complete picture of a woman’s metabolic health.
Why Does This Matter During Pregnancy?
During pregnancy, the body naturally becomes less responsive to insulin, particularly in the later stages. Women who already have insulin resistance may therefore have a higher risk of developing gestational diabetes.
PMOS is also associated with an increased risk of pregnancy complications, including pre-eclampsia and premature birth. This does not mean every woman with PMOS will experience these complications, but it highlights the importance of assessing blood sugar health before conception and monitoring it during pregnancy.
What Should Be Checked Before Conception?
The International Evidence-Based Guideline recommends offering a 75-gram oral glucose tolerance test to women with PMOS who are planning pregnancy or seeking fertility treatment, regardless of body weight. The test assesses how effectively the body processes glucose.
If testing has not been carried out before conception, it should be offered at the first antenatal visit and repeated at 24–28 weeks of pregnancy.
When raised blood sugar is identified, doctors may recommend changes in diet, physical activity or medication, depending on individual needs. Women experiencing irregular ovulation may also require fertility treatment.
Assessing metabolic and reproductive health together allows doctors to identify concerns early and plan appropriate care. For women with PMOS, preparing for pregnancy involves understanding not only ovulation and menstrual health, but also how the body manages blood sugar.

